Balansag, Roger L.

HRN: 27-35-60  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2025
CEFTRIAXONE 1G (VIAL)
06/21/2025
06/27/2025
IV
2g
OD
Cap -MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: